Skip to main content

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses.

The appeals called the process “wildly prejudicial.”

Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported.

Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency.

One consultant to an applicant said the selections felt “predetermined.”

The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied.

A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.”

The five winning applicants, called “pharmaceutical processors,” have a year from winning the licenses to become operational.

The multistate operators that won three of the five licenses were New York-based Columbia Care, Illinois-headquartered PharmaCann and Green Leaf Medical, which is based in Maryland.

Original Article Source: https://mjbizdaily.com/virginias-fledgling-cbd-program-criticized-multistate-mmj-operators/

Comments

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...

Dixie Brands To Enter Oklahoma Marijuana Market Through Deal With Globus

Dixie Brands, a Denver-based consumer packaged goods company, said it is entering the Oklahoma medical cannabis market through a manufacturing and distribution agreement with Globus Holdings. Oklahoma marks the sixth state where Dixie has operations. The company trades on the Canadian Securities Exchange under the ticker symbol  DIXI . There are roughly 130,000 medical marijuana patients in Oklahoma, where voters approved a ballot measure in June 2018. For more details about the agreement, click here . Get access to more in-depth market analysis, premium features on cannabis investing trends and monthly executive webcasts with an  Investor Intelligence subscription . Original Article Source: https://mjbizdaily.com/dixie-brands-enters-oklahoma-marijuana-market-through-deal-with-globus/

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...